Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
